Ir Biosciences Holdings Inc (IRBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,270 | -4,930 | -2,140 | -3,320 | -6,460 |
| Depreciation Amortization | 1,040 | 680 | 580 | 280 | 1,090 |
| Other Working Capital | -2,850 | -2,500 | 950 | 350 | 1,120 |
| Other Operating Activity | 6,650 | 6,470 | 330 | 2,410 | 1,380 |
| Operating Cash Flow | $-430 | $-280 | $-280 | $-280 | $-2,870 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | 0 | -2 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $-2 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 150 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $150 | $0 | $0 | $0 | $0 |
| Beginning Cash Position | 280 | 280 | 280 | 280 | 3,150 |
| End Cash Position | 0 | 0 | 0 | 0 | 280 |
| Net Cash Flow | $-280 | $-280 | $-280 | $-280 | $-2,870 |
| Free Cash Flow | |||||
| Operating Cash Flow | -430 | -280 | -280 | -280 | -2,870 |
| Free Cash Flow | -430 | -280 | -280 | -280 | -2,870 |